Lantheus, RefleXion to collaborate on prostate cancer treatment
September 13, 2021 -- Lantheus Medical Imaging parent Lantheus Holdings and radiation therapy equipment developer RefleXion Medical have signed a development and marketing partnership to evaluate the use of Lantheus' prostate-specific membrane antigen-targeted PET agent piflufolastat F-18 with RefleXion's X1 biology-guided radiotherapy system. Read More
B dot Medical unveils scanning magnet for proton therapy
September 10, 2021 -- B dot Medical has manufactured a scanning magnet for a compact proton therapy system currently under development. Read More
ASTRO calls proposed CMS cuts 'draconian'
September 9, 2021 -- The American Society for Radiation Oncology (ASTRO) told the U.S. Centers for Medicare and Medicaid Services (CMS) that its proposed changes to the 2022 Medicare Physician Fee Schedule could lead to draconian cuts in cancer care. Read More
NorthStar, Point Biopharma ink Ac-225 supply deal
September 8, 2021 -- NorthStar Medical Radioisotopes and Point Biopharma Global have signed a supply agreement covering the development and commercialization of the medical radioisotope actinium-225 (Ac-225). Read More
Telix, Kettering to research PSMA radiotracer
September 8, 2021 -- Kettering Health and Telix Pharmaceuticals have signed a deal to study Telix's investigational prostate-specific membrane antigen (PSMA)-targeting radiopharmaceutical, illuccix. Read More
Hermes, Isotopia sign deal on dosimetry
September 7, 2021 -- Nuclear medicine software developer Hermes Medical Solutions has signed a collaboration with Isotopia Molecular Imaging to support clinical studies to demonstrate the positive effects of personalized dosimetry and modulated radiopharmaceutical therapy on patient outcomes. Read More
Second-look PET/CT catches cancer spread
September 2, 2021 -- Is a second PET/CT scan worth it before radiotherapy treatment? Swiss clinicians think so, especially when there are delays of more than four weeks after initial scans in patients with advanced head and neck squamous cell cancer, according to a study published August 29 in Clinical and Translational Radiation Oncology. Read More
Akumin closes on Alliance acquisition
September 2, 2021 -- Akumin has completed its acquisition of Alliance HealthCare Services, a national provider of radiology and oncology services to hospitals, health systems, and physician groups. Read More
Elekta acquires Turkish distributor
September 2, 2021 -- Radiation oncology firm Elekta has acquired its Turkish distributor, Özyürek Mümessillik ve DıŞ Ticaret. The move will improve Elekta's market access in the region and strengthen its relationship with customers, the company said. Read More
Elekta to establish foundation to improve cancer care access
August 27, 2021 -- Radiation oncology firm Elekta is establishing the Elekta Foundation to support projects in low- and middle-income countries to improve access to cancer care. Read More
Special Feature
IMV: Imaging boosts precision in radiation therapy

Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more